Table 4.

Weighted Costs by Initial Procedure in Treatment of VMA (US $) for Facility and Non-Facility Billing

	Facility Billing				Non-Facility Billing
Initial Procedure	Total Professional Fees	Total Hospital Fees	Total Pharmaceutical Fees	Total fees	Total Professional Fees	Total ASC Fees	Total Pharmaceutical Fees	Total fees
Scenario 1, PPV	2,859	5,073	0	7,931	3,027	2,775	0	5,802
Scenario 2a (ocriplasmin 26.5%)	2,505	4,522	3,950	10,977	3,042	2,039	3,950	9,031
Scenario 2b (ocriplasmin 41%)	2,342	4,332	3,950	10,624	2,879	1,938	3,950	8,767
Scenario 3, saline	2,925	5,073	100	8,098	3,231	2,497	100	5,828

VMA = vitreomacular adhesion, US = United States, ASC = ambulatory surgery center, PPV = pars plana vitrectomy, Ocriplasmin (27%) = 27% initial success rate with ocriplasmin, Ocriplasmin (41%) = 41% initial success rate with ocriplasmin